Literature DB >> 33652348

Regulatory T cells in autoimmune hepatitis: an updated overview.

Maria Serena Longhi1, Giorgina Mieli-Vergani2, Diego Vergani3.   

Abstract

Regulatory T-cells (Tregs) are key players in the maintenance of immune homeostasis by preventing immune responses to self-antigens. Defects in Treg frequency and/or function result in overwhelming CD4 and CD8 T cell immune responses participating in the autoimmune attack. Perpetuation of autoimmune damage is also favored by Treg predisposition to acquire effector cell features upon exposure to a proinflammatory challenge. Treg impairment plays a permissive role in the initiation and perpetuation of autoimmune liver diseases, namely autoimmune hepatitis, primary biliary cholangitis and primary sclerosing cholangitis. In this Review, we outline studies reporting the role of Treg impairment in the pathogenesis of these conditions and discuss methods to restore Treg number and function either by generation/expansion in the test tube or through in vivo expansion upon administration of low dose IL-2. Challenges and caveats of these potential therapeutic strategies are also reviewed and discussed.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmune hepatitis; Effector lymphocytes; Immune tolerance; Immunotherapy; Regulatory T cells

Mesh:

Substances:

Year:  2021        PMID: 33652348      PMCID: PMC8044040          DOI: 10.1016/j.jaut.2021.102619

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  135 in total

1.  Inducing and expanding regulatory T cell populations by foreign antigen.

Authors:  Karsten Kretschmer; Irina Apostolou; Daniel Hawiger; Khashayarsha Khazaie; Michel C Nussenzweig; Harald von Boehmer
Journal:  Nat Immunol       Date:  2005-10-23       Impact factor: 25.606

2.  Activated CD4+CD25+ T cells selectively kill B lymphocytes.

Authors:  Dong-Mei Zhao; Angela M Thornton; Richard J DiPaolo; Ethan M Shevach
Journal:  Blood       Date:  2006-01-17       Impact factor: 22.113

3.  MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORγt⁺ T cells.

Authors:  Caspar Ohnmacht; Joo-Hong Park; Sascha Cording; James B Wing; Koji Atarashi; Yuuki Obata; Valérie Gaboriau-Routhiau; Rute Marques; Sophie Dulauroy; Maria Fedoseeva; Meinrad Busslinger; Nadine Cerf-Bensussan; Ivo G Boneca; David Voehringer; Koji Hase; Kenya Honda; Shimon Sakaguchi; Gérard Eberl
Journal:  Science       Date:  2015-07-09       Impact factor: 47.728

4.  Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study.

Authors:  G V Gregorio; B Portmann; J Karani; P Harrison; P T Donaldson; D Vergani; G Mieli-Vergani
Journal:  Hepatology       Date:  2001-03       Impact factor: 17.425

Review 5.  Regulatory T-cells in autoimmune diseases: challenges, controversies and--yet--unanswered questions.

Authors:  Charlotte R Grant; Rodrigo Liberal; Giorgina Mieli-Vergani; Diego Vergani; Maria Serena Longhi
Journal:  Autoimmun Rev       Date:  2014-10-16       Impact factor: 9.754

6.  An essential role for Scurfin in CD4+CD25+ T regulatory cells.

Authors:  Roli Khattri; Tom Cox; Sue-Ann Yasayko; Fred Ramsdell
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

7.  Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces.

Authors:  Yuri P Rubtsov; Jeffrey P Rasmussen; Emil Y Chi; Jason Fontenot; Luca Castelli; Xin Ye; Piper Treuting; Lisa Siewe; Axel Roers; William R Henderson; Werner Muller; Alexander Y Rudensky
Journal:  Immunity       Date:  2008-04       Impact factor: 31.745

8.  Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cells.

Authors:  Matthias Hardtke-Wolenski; Katja Fischer; Fatih Noyan; Jerome Schlue; Christine S Falk; Maike Stahlhut; Norman Woller; Florian Kuehnel; Richard Taubert; Michael P Manns; Elmar Jaeckel
Journal:  Hepatology       Date:  2013-07-01       Impact factor: 17.425

9.  Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis.

Authors:  Maria Serena Longhi; Francesca Meda; Pengyun Wang; Marianne Samyn; Giorgina Mieli-Vergani; Diego Vergani; Yun Ma
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

10.  Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis.

Authors:  Laura Elisa Buitrago-Molina; Julia Pietrek; Fatih Noyan; Jerome Schlue; Michael P Manns; Heiner Wedemeyer; Matthias Hardtke-Wolenski; Elmar Jaeckel
Journal:  J Autoimmun       Date:  2020-12-30       Impact factor: 7.094

View more
  8 in total

1.  Missing Causality and Heritability of Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2022-10-19       Impact factor: 3.487

Review 2.  Interplay between Mast Cells and Regulatory T Cells in Immune-Mediated Cholangiopathies.

Authors:  Natalia M Krajewska; Rémi Fiancette; Ye H Oo
Journal:  Int J Mol Sci       Date:  2022-05-24       Impact factor: 6.208

Review 3.  The Regulatory-T-Cell Memory Phenotype: What We Know.

Authors:  Julia N Khantakova; Aleksey S Bulygin; Sergey V Sennikov
Journal:  Cells       Date:  2022-05-19       Impact factor: 7.666

Review 4.  Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders - Advances and challenges.

Authors:  Tapas Kumar Goswami; Mithilesh Singh; Manish Dhawan; Saikat Mitra; Talha Bin Emran; Ali A Rabaan; Abbas Al Mutair; Zainab Al Alawi; Saad Alhumaid; Kuldeep Dhama
Journal:  Hum Vaccin Immunother       Date:  2022-03-03       Impact factor: 4.526

Review 5.  Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease.

Authors:  Mengqin Yuan; Xue Hu; Lichao Yao; Yingan Jiang; Lanjuan Li
Journal:  Stem Cell Res Ther       Date:  2022-05-03       Impact factor: 8.079

6.  BTN2A2 protein negatively regulates T cells to ameliorate collagen-induced arthritis in mice.

Authors:  Xueping He; Rong Hu; Peng Luo; Jie Gao; Wenjiang Yang; Jiaju Li; Youjiao Huang; Feng Han; Laijun Lai; Min Su
Journal:  Sci Rep       Date:  2021-09-29       Impact factor: 4.379

Review 7.  Autoimmmune hepatitis.

Authors:  Benedetta Terziroli Beretta-Piccoli; Giorgina Mieli-Vergani; Diego Vergani
Journal:  Cell Mol Immunol       Date:  2021-09-27       Impact factor: 11.530

Review 8.  Impact of Antigen Presentation Mechanisms on Immune Response in Autoimmune Hepatitis.

Authors:  Rossella Fasano; Eleonora Malerba; Marcella Prete; Antonio Giovanni Solimando; Alessio Buonavoglia; Nicola Silvestris; Patrizia Leone; Vito Racanelli
Journal:  Front Immunol       Date:  2022-01-18       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.